VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
0.0880
+0.0093 (11.82%)
At close: Aug 3, 2026, 4:00 PM EDT
0.0823
-0.0057 (-6.48%)
After-hours: Aug 3, 2026, 5:14 PM EDT
Company Description
VSee Health, Inc. provides telehealth care solutions in the United States.
The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions.
It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates.
The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives.
The company is headquartered in Newton, Massachusetts.
VSee Health, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 209 |
| CEO | Imoigele Aisiku |
Contact Details
Address: One Gateway Center, Suite 507 Newton, Massachusetts 02458 United States | |
| Website | vseehealth.com |
Stock Details
| Ticker Symbol | VSEE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1864531 |
| CUSIP Number | 92919Y102 |
| ISIN Number | US92919Y1029 |
| Employer ID | 86-2970927 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Erika Chuang Ph.D. | Chief of Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2026 | 8-K | Current Report |
| Jul 24, 2026 | 8-K | Current Report |
| Jul 20, 2026 | DEF 14A | Other definitive proxy statements |
| Jul 10, 2026 | PRE 14A | Other preliminary proxy statements |
| Jul 10, 2026 | 8-K | Current Report |
| Jul 7, 2026 | 8-K | Current Report |
| Jun 26, 2026 | 424B3 | Prospectus |
| Jun 26, 2026 | 8-K | Current Report |
| Jun 11, 2026 | 424B3 | Prospectus |
| Jun 11, 2026 | 8-K | Current Report |